Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

$ 8.50

4.5
(524)
In stock
Description

Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma

REST regulates oncogenic properties of glioblastoma stem cells

CD4 Polyclonal Antibody (19068-1-AP)

An expression based REST signature predicts patient survival and

PDF) Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

REST in the Road Map of Brain Development

REST ceRNA network construction. (A,B) The volcanic map showing

Expression of the repressor element 1 silencing transcription factor

Frontiers Comprehensive Analysis of REST/NRSF Gene in Glioma and Its ceRNA Network Identification

Evaluating cancer cell line and patient-derived xenograft

Frontiers Case Report: Two clinical cases of Wilms tumor

Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

A) Retinoic acid (RA) down-regulates repressor element-1 silencing